Arecor Therapeutics plc (LON:AREC – Get Free Report) rose 2.6% on Friday . The company traded as high as GBX 78 ($0.98) and last traded at GBX 78 ($0.98). Approximately 42 shares changed hands during mid-day trading, a decline of 100% from the average daily volume of 14,401 shares. The stock had previously closed at GBX 76 ($0.96).
Arecor Therapeutics Price Performance
The firm has a 50-day moving average of GBX 72.25 and a 200-day moving average of GBX 100.26. The company has a debt-to-equity ratio of 5.51, a current ratio of 1.37 and a quick ratio of 6.24. The stock has a market cap of £29.45 million, a PE ratio of -278.57 and a beta of -0.18.
Arecor Therapeutics Company Profile
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
See Also
- Five stocks we like better than Arecor Therapeutics
- 10 Best Airline Stocks to Buy
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Stock Market Sectors: What Are They and How Many Are There?
- Top-Performing Non-Leveraged ETFs This Year
- Dividend Capture Strategy: What You Need to Know
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
